Understanding Genotoxic, Mutagenic, and Carcinogenic Impurities in Pharmaceutical Products

In the realm of pharmaceuticals, ensuring the safety and efficacy of drugs is paramount. However, despite rigorous testing and Regulatory oversight, certain substances known as Genotoxic, Mutagenic, and Carcinogenic impurities can pose significant risks to human health. These impurities, even in minute quantities, have the potential to cause DNA damage, mutations, and ultimately, cancer. Understanding these impurities and implementing strategies to mitigate their presence is crucial for safeguarding public health.